SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3111XOMA 24% on last night's news about gevokizumab in osteoarthritis.nigel bates-3/5/2014
3110Of course, Stupid of me to have even asked.tom pope-3/3/2014
3109siliconinvestor.com FWIW. Regards, DewDewDiligence_on_SI-3/3/2014
3108Friday.mopgcw-3/3/2014
3107Today? Or Friday?tom pope-3/3/2014
3106MNTA dropped 14%???mopgcw-3/3/2014
3105Summit 20% - Oxford, UK, 11 February 2014 - Summit (AIM: SUMM), a drug discovernigel bates-2/12/2014
3104Addex 25%: GENEVA, Switzerland, Feb. 7, 2014 (GLOBE NEWSWIRE) -- (SIX:ADXN), Adnigel bates-2/10/2014
3103Active Biotech 30% - JERUSALEM, Israel & LUND, Sweden, January 24, 2014 - Tnigel bates-1/24/2014
3102There are two answers to that question, both correct: 1. Half a day 2. half a dtom pope-1/14/2014
3101I did bite the bullet and bought some ICPT earlier today. Was down for a while,Biotech Jim-1/14/2014
3100I did not buy any IPRT, but instead I bought some CLV. CLV is the preferred stoBiotech Jim-1/14/2014
3099I did, and sold, too, which was just as well. The gist of the down comments seetom pope-1/14/2014
3098ICPT, now off some $128, about 35%. I am watching it a bit, wondering if I shouBiotech Jim-1/14/2014
3097This is just the beginning, IMO, of regression to a more realistic valuation.DewDiligence_on_SI-1/13/2014
3096ICPT down 30% on side effect worries after the 4-5x move of last week. JonRobohogs-1/13/2014
3095MYGN down more than 15% to a two-year low. Some downgrades based on proposed reFiloF-12/30/2013
3094ENTA -22% on GILD's release of 'ION' data in genotype-1 HCV; musingsDewDiligence_on_SI-12/18/2013
3093NWBO down about 26% - new public offeringJohn McCarthy-11/20/2013
3092SRPT nearly 60%: CAMBRIDGE, MA--(Marketwired - Nov 12, 2013) - Sarepta Therapeunigel bates-11/12/2013
3091ZLCS <i> Nov 11 (Reuters) - Zalicus Inc said it would stop developing an tom pope-11/11/2013
3090GENT No news that I have seen. Until today intraday drops generally reversed IRWIN JAMES FRANKEL-11/7/2013
3089I was wondering if there was more to it then a pullback after the big move up, Ighmm-11/7/2013
3088GENT down 15% - no idea why other than a correction of the strong up moveIRWIN JAMES FRANKEL-11/7/2013
3087CRIS and NPSP around 20% on results.nigel bates-11/6/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News